CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 90 enrolled
Drug / intervention
Lipase Thera-blend +2 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07020494
NCT07020494N/ACompleted

A Randomized, Triple-blind, Placebo Controlled, Parallel Clinical Trial Investigating the Efficacy and Safety of a Lipase Thera-blend and a Lipase Thera-blend + Tributyrin on Memory in Healthy Adults With Self-reported Memory Problems

Enzymedica·interventional·Posted Jun 13, 2025·Updated Mar 31, 2026

In Brief

A clinical study evaluating Lipase Thera-blend, Lipase Thera-blend + tributyrin, and 1 other intervention for Self-reported Memory Problems and Memory. Completed, enrolled 90 participants across 1 site.

Detailed Summary

The goal of this clinical trial is to investigate the efficacy and safety of Lipase Thera-blend and Lipase Thera-blend + tributyrin on memory in healthy adults with self-reported memory problems. The main question\[s\] it aims to answer \[is/are\]: Does of Lipase Thera-blend improve memory in healthy adults? Does Lipase Thera-blend + tributyrin improve memory in healthy adults? Researchers will compare Lipase Thera-blend and Lipase Thera-blend + tributyrin against a placebo to see if the investigational products improve memory parameters. Participants will be asked to consume either placebo, Lipase Thera-blend, or Lipase Thera-blend + tributyrin and asked to complete memory questionnaires to assess memory.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesCanada
CollaboratorsKGK Science Inc.

Timeline

N/ACompletedFinished
2026
First PostedJun 13, 2025
Enrollment StartAug 25, 2025
Primary CompletionFeb 13, 2026
TodayJul 1, 2026
Enrollment to primary: 6 monthsPosted 1.1 years ago

Interventions

Lipase Thera-blenddietary

Participants will be instructed to consume take one capsule three times a day with food for the duration of the study period.

Lipase Thera-blend + tributyrindietary

Participants will be instructed to consume take one capsule three times a day with food for the duration of the study period.

Placeboother

Participants will be instructed to consume take one capsule three times a day with food for the duration of the study period.